Aspirin plus Rivaroxaban versus Rivaroxaban alone for the prevention of venous stent thrombosis among patients with post-thrombotic syndrome: the multicenter, multinational, randomized, open-label ARIVA trial - Barco, Stefano; Jalaie, Houman; Sebastian, Tim; Wolf, Simon; Fumagalli, Riccardo M.; Lichtenberg, Michael; Zeller, Thomas; Erbel, Christian; Schlager, Oliver; Kucher, Nils (Circulation, 2025)
Gesehen am 20.01.2026